Skip to content

Tenofovir PrEP arm dropped in women's HIV prevention trial

'Less education' associated with PrEP and PEP use: only one in five gay men yet aware of PrEP

High levels of PrEP efficacy demanded by gay men before they consider it a replacement for condoms

PrEP acceptable to gay men and few report that it would change their risk behaviour

Pre-exposure prophylaxis

High levels of unmet need for family planning in people with HIV - couples unaware of conception and contraception options

Gay men’s PrEP study final results: near 90% efficacy in men who took drug, but adherence even lower than thought

Robert Grant, iPrEx study lead investigator. ©IAS/Marcus Rose/Worker's Photos

From 'what if' to 'what now': implementing the new prevention technologies

Anthony Fauci, National Institute of Allergy and Infectious Diseases at the National Institute of Health, USA. Photo©IAS/Steve Forrest/Workers' Photos

Small study shows women on stable HIV therapy have very low levels of HIV and high drug concentrations in genital fluids

Images from presentation by Anandi Sheth of Emory University School of Medicine, Division of Infectious Diseases, Atlanta, United States.